Arvee Laboratories (India) Ltd
Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Employee Count count ・Standalone data |
|
||||||||
| Raw Material Sourcing - Share Imported % ・Standalone data |
|||||||||
| Export Revenue Share % ・Standalone data |
|||||||||
| Capacity Utilization (Specialty Chemicals) % ・Standalone data |
|||||||||
| Production Volume (Specialty Chemicals) MT ・Standalone data |
|||||||||
| Sales Volume (Specialty Chemicals) MT ・Standalone data |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Delay/default in the payment of fines/penalties/dues etc. to authority
- NSE levies Rs.10,000 plus GST fine on Arvee Laboratories for Regulation 44 non-compliance.
-
Board Meeting - Intimation
- ARVEE LABORATORIES (INDIA) LIMITED has informed about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the …
-
Board Meeting - Intimation
- ARVEE LABORATORIES (INDIA) LIMITED has informed about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the …
-
Board Meeting - Financial Results/Other business matters
- Board meeting on 3 November 2026 to approve standalone unaudited results for quarter ended 30 September 2026.
-
Shareholders meeting
- AGM held 29 Sep 2026; all four resolutions passed, including FY26 accounts adoption and director reappointments.
Annual reports
-
Annual Report 2026
from nse
-
Annual Report 2025
from nse
-
Annual Report 2024
from nse
-
Annual Report 2023
from nse
-
Annual Report 2022
from nse
-
Annual Report 2021
from nse
Products & applications:[1]
a) Polymer modifiers:[2]
DMS /DCBMS salt, Na-SIPA, Li-SIPA
and SIPHE-40, used to introduce cationic-dyeability into polyester, make water-soluble /dispersible polyester resins, textile sizing /coatings and synthetic-fibre spin finishes. Contrast-media intermediates: 5-NIPA, DM-5-NIPA, MM-5-NIPA, 5-HIPA, 5-AIPA, dimethyl 5-AIPA, 3,5-DNBA and 3,5-diaminobenzoic acid. Drug intermediates: 2-acetylthiophene, thiophene-2-carboxaldehyde, 4aminopyridine and 2-chloro-5-nitrobenzoic acid.[3][4]